Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 1, 2009, Pages 89-93

  Khoo, Cheen Peen ^a,c   Valorani, M G ^a,b   Brittan, Mairi ^a   Alison, Malcolm R ^a   Warnes, Gary ^a   Johansson, Ulrika ^a   Hawa, Mohammed ^a   Pozzilli, Paolo ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Fondazione Livio Patrizi   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Autoimmune diabetes; Bone marrow cells; Endothelial progenitor cells; NOD mouse

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL COUNT; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL STIMULATION; CELL THERAPY; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE ACTIVATED CELL SORTING; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PATHOGENESIS; PRIORITY JOURNAL; STEM CELL; ANGIOGENESIS; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL THERAPY; BONE MARROW CELL; CYTOLOGY; ENDOTHELIUM CELL; FEMALE; FEMUR; FLOW CYTOMETRY; ILIAC BONE; IMPAIRED GLUCOSE TOLERANCE; MALE; METHODOLOGY; PATHOLOGY; TIBIA;

ANIMALS; BONE MARROW CELLS; CELL COUNT; DIABETES MELLITUS, TYPE 1; ENDOTHELIAL CELLS; FEMALE; FEMUR; FLOW CYTOMETRY; ILIUM; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; NEOVASCULARIZATION, PHYSIOLOGIC; PREDIABETIC STATE; STEM CELLS; TIBIA; TISSUE THERAPY;

EID: 65549159482     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.898     Document Type: Article

References (26)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174.
3. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
4. Caballero S, Sengupta N, Afzal A, et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007; 56: 960-967.
5. Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-199.
6. Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449-1457.
7. Emanueli C, Monopoli A, Kraenkel N, et al. Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice. Br J Pharmacol 2007; 150: 873-882.
8. Thum T, Fraccarollo D, Schultheiss M, et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007; 56: 666-674.
9. Lampeter EF, Signore A, Gale EA, et al. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 703-708.
10. Mansfield K, Beales P, Williams A, et al. The breeding housing and life-maintenance of the non-obese diabetic mouse. Anim Technol 1992; 43: 29-37.
11. National Institutes of Health (NIH). Principles of laboratory animal care, Publication no.83-25. Bethesda, MD: National Institutes of Health, revised 1985.
12. HMSO. Her Majesty's Stationary Office. Animals (Scientific Procedures) ACT: London, 1986.
13. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107: 1395-1402.
14. Rongish BJ, Hinchman G, Doty MK, et al. Relationship of the extracellular matrix to coronary neovascularization during development. J Mol Cell Cardiol 1996; 28: 2203-2215.
15. Baldwin HS, Shen HM, Yan HC, et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 1994; 120: 2539-2553.
16. Zhang W, Zhang G, Jin H, et al. Characteristics of bone marrow-derived endothelial progenitor cells in aged mice. Biochem Biophys Res Commun 2006; 348: 1018-1023.
17. Mathews V, Hanson PT, Ford E, et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004; 53: 91-98.
18. Brittan M, Chance V, Elia G, et al. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 2005; 128: 1984-1995.
19. Fujii H, Hirose T, Oe S, et al. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol 2002; 36: 653-659.
20. Hatzopoulos AK, Folkman J, Vasile E, et al. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 1998; 125: 1457-1468.
21. Ishizawa K, Kubo H, Yamada M, et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 2004; 556: 249-252.
22. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436.
23. Taniguchi E, Kin M, Torimura T, et al. Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 2006; 130: 521-531.
24. Amano K, Okigaki M, Adachi Y, et al. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. J Mol Cell Cardiol 2004; 36: 469-480.
25. Khoo CP, Pozzilli P, Alison MR. Endothelial progenitor cells and their potential therapeutic applications. Regen Med 2008; 3: 863-876.
26. Lin Y, Weisdorf DJ, Solovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-77.